World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02084550
Date of registration: 05/03/2014
Prospective Registration: Yes
Primary sponsor: Aarhus University Hospital
Public title: Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative Colitis AMINOPOUCH
Scientific title: Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative Colitis: a Randomized, Assessor-blinded, Placebo-controlled Trial
Date of first enrolment: September 2015
Target sample size: 8
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT02084550
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Name:     Søren Laurberg, MD, DMSc
Address: 
Telephone:
Email:
Affiliation:  Department of Surgery P, Aarhus University Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with ulcerative colitis who are having an ileal pouch-anal anastomosis
performed, 18 < age < 50, written informed consent.

Exclusion Criteria:

- Inability to understand written Danish, postmenopause, severe asthma, diabetes
mellitus, severe rheumatologic disease, severe comorbidity (ASA group III-IV) in
general. Acute or progressing liver failure, uremia without possibility for dialysis,
phenylketonuria, defects in amino acid metabolism. Participation in scientific studies
in the preceding year, where ionizing radiation has been used, including significant
x-ray investigations.



Age minimum: 18 Years
Age maximum: 50 Years
Gender: All
Health Condition(s) or Problem(s) studied
Ulcerative Colitis
Intervention(s)
Dietary Supplement: Vaminolac
Other: Saline
Primary Outcome(s)
Phenylalanine kinetics [Time Frame: 6 hours]
Tyrosine kinetics [Time Frame: 6 hours]
Palmitate balance [Time Frame: 5 hours]
Secondary Outcome(s)
Plasma changes in hormones and energy sources [Time Frame: 6 hours]
Secondary ID(s)
1-10-72-48-14
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history